New MRI scan could spot kidney trouble early in fabry patients
NCT ID NCT05923788
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a special MRI scan called T1 mapping can detect kidney damage in people with Fabry disease, a rare genetic disorder. Researchers compared MRI results from 70 adults with and without Fabry disease. The goal was to see if this non-invasive scan could help doctors diagnose and monitor kidney problems without needing a biopsy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this MRI method could become a non-invasive tool to detect kidney damage earlier in Fabry disease and help guide treatment decisions.
- What could go wrong
- This is a small, completed observational study, not a treatment trial. The MRI technique may not prove accurate enough for routine clinical use, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FABRY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hopital Edouard Herriot
Lyon, 69003, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can early enzyme therapy save kidneys in fabry disease?
- Can continued lucerastat access help fabry patients?
- Can a single gene infusion rewrite the story of fabry disease?
- Fabry disease sperm study halted early
- Heart study reveals hidden link between blood vessels and muscle blockage
- Taiwan study sheds light on rare fabry mutation and treatment effects